Ohio State University Comprehensive Cancer Center
🇺🇸United States
Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy
Not Applicable
Withdrawn
- Conditions
- Interventions
Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 1
- Conditions
- Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRefractory Follicular LymphomaRefractory Marginal Zone LymphomaRefractory Non-Hodgkin LymphomaRefractory Transformed Indolent Non-Hodgkin LymphomaHematopoietic Cell Transplantation RecipientRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Marginal Zone Lymphoma
- Interventions
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2021-10-06
- Target Recruit Count
- 19
- Registration Number
- NCT03583424
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Stress and Immunity Breast Cancer Project
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2018-07-06
- Target Recruit Count
- 231
- Registration Number
- NCT03578627
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2022-10-12
- Target Recruit Count
- 36
- Registration Number
- NCT03568526
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 1
Active, not recruiting
- Conditions
- Folate Receptor Alpha PositiveRecurrent Uterine Serous CarcinomaBRCA2 Gene MutationRecurrent Ovarian CarcinomaBRCA1 Gene MutationRecurrent Uterine CarcinosarcomaPlatinum Resistant Ovarian CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus Carcinoma
- Interventions
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2023-06-26
- Target Recruit Count
- 25
- Registration Number
- NCT03552471
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2021-09-08
- Target Recruit Count
- 20
- Registration Number
- NCT03535701
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2024-01-16
- Target Recruit Count
- 48
- Registration Number
- NCT03532581
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-05-16
- Last Posted Date
- 2024-03-18
- Target Recruit Count
- 16
- Registration Number
- NCT03525925
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2023-11-08
- Target Recruit Count
- 28
- Registration Number
- NCT03513562
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2023-07-21
- Target Recruit Count
- 350
- Registration Number
- NCT03502200
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
© Copyright 2024. All Rights Reserved by MedPath